OMEROS CORP

OMER · Nasdaq · SIC 2834: Pharmaceutical Preparations
297
SEC Filings

Business Summary

Overview Omeros Corporation (Omeros, the Company or we) is an innovative, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. Our complement-targeted product, product candidates, and therapeutic programs are primarily focused on diseases and disorders associated with the lectin and/...

Next Earnings

Q2 FY2026 — expected 2026-08-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionOMERdiscussed_in_filing Cybersecurity
topic_mentionOMERdiscussed_in_filing Trusted Computing
topic_mentionOMERdiscussed_in_filing Blockchain & Crypto
topic_mentionOMERdiscussed_in_filing Capital Expenditure
topic_mentionOMERdiscussed_in_filing Regulation
topic_mentionOMERdiscussed_in_filing Healthcare & Bio
topic_mentionOMERdiscussed_in_filing Platform & Ecosystem
topic_mentionOMERdiscussed_in_filing Sovereign & Government
topic_mentionOMERdiscussed_in_filing Cybersecurity
topic_mentionOMERdiscussed_in_filing Trusted Computing
topic_mentionOMERdiscussed_in_filing Blockchain & Crypto
topic_mentionOMERdiscussed_in_filing Capital Expenditure
topic_mentionOMERdiscussed_in_filing Regulation
topic_mentionOMERdiscussed_in_filing Healthcare & Bio
topic_mentionOMERdiscussed_in_filing Platform & Ecosystem
topic_mentionOMERdiscussed_in_filing Sovereign & Government
topic_mentionOMERdiscussed_in_filing Cybersecurity
topic_mentionOMERdiscussed_in_filing Trusted Computing
topic_mentionOMERdiscussed_in_filing Blockchain & Crypto
topic_mentionOMERdiscussed_in_filing Capital Expenditure

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001437749-26-010636EDGAR68K words
2025-03-312024-12-310001437749-25-010216EDGAR—
2024-04-012023-12-310001437749-24-010416EDGAR—
2023-03-132022-12-310001558370-23-003575EDGAR—
2022-03-012021-12-310001558370-22-002582EDGAR—
2021-03-012020-12-310001558370-21-002177EDGAR—
2020-03-022019-12-310001558370-20-001891EDGAR—
2019-03-012018-12-310001628280-19-002324EDGAR—
2018-03-012017-12-310001285819-18-000003EDGAR—
2017-03-162016-12-310001285819-17-000004EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001437749-25-034826EDGAR30K words
2025-08-142025-06-300001437749-25-026933EDGAR—
2025-05-152025-03-310001437749-25-017213EDGAR—
2024-11-132024-09-300001437749-24-034903EDGAR—
2024-08-072024-06-300001437749-24-025181EDGAR—
2024-05-152024-03-310001437749-24-017047EDGAR—
2023-11-092023-09-300001437749-23-031250EDGAR—
2023-08-092023-06-300001558370-23-014095EDGAR—
2023-05-092023-03-310001558370-23-008814EDGAR—
2022-11-092022-09-300001558370-22-017153EDGAR—
2022-08-092022-06-300001558370-22-012884EDGAR—
2022-05-102022-03-310001558370-22-008120EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001437749-26-010634EDGAR5K words
2026-01-070001437749-26-000820EDGAR—
2025-12-290001437749-25-038758EDGAR—
2025-12-010001437749-25-036507EDGAR—
2025-11-130001437749-25-034824EDGAR—
2025-10-150001437749-25-030968EDGAR—
2025-08-140001437749-25-026931EDGAR—
2025-07-250001104659-25-070554EDGAR—
2025-07-020001437749-25-021959EDGAR—
2025-05-150001437749-25-017211EDGAR—

297 total filings indexed. 265 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001285819
TickerOMER
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedWA

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 268003e9db159b9c6ef355e2a25e5b3ab36fa9beade0955c0cc4e7a1c0f014d6
parent: 4a4b666cdb4de177a6b91b5847ead7ce4bbc0f82a84d3081a23ef7134d48c963
content hash: 84037199d9d01b2eeecbc941db559d55a1934fc64f9d6380aeb45cea8f3157d1
signed: 2026-04-13T04:46:43.122Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf